BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,890
+960 (6.43%)
At close: Feb 27, 2026
-10.07%
Market Cap 506.06B
Revenue (ttm) 165.64B
Net Income (ttm) -7.70B
Shares Out 31.85M
EPS (ttm) -242.14
PE Ratio n/a
Forward PE 132.59
Dividend n/a
Ex-Dividend Date n/a
Volume 909,038
Average Volume 319,488
Open 14,890
Previous Close 14,930
Day's Range 14,870 - 16,210
52-Week Range 12,800 - 21,250
Beta 0.76
RSI 59.27
Earnings Date Mar 13, 2026

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 650
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.